Cargando…

A Comparative Study of Systems Pharmacology and Gene Chip Technology for Predicting Targets of a Traditional Chinese Medicine Formula in Primary Liver Cancer Treatment

Background: The systems pharmacology approach is a target prediction model for traditional Chinese medicine and has been used increasingly in recent years. However, the accuracy of this model to other prediction models is yet to be established. Objective : To compare the systems pharmacology modelwi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Songzhe, Sun, Yang, Sun, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926147/
https://www.ncbi.nlm.nih.gov/pubmed/35308212
http://dx.doi.org/10.3389/fphar.2022.768862
_version_ 1784670176511262720
author Li, Songzhe
Sun, Yang
Sun, Yue
author_facet Li, Songzhe
Sun, Yang
Sun, Yue
author_sort Li, Songzhe
collection PubMed
description Background: The systems pharmacology approach is a target prediction model for traditional Chinese medicine and has been used increasingly in recent years. However, the accuracy of this model to other prediction models is yet to be established. Objective : To compare the systems pharmacology modelwithexperimental gene chip technology by using these models to predict targets of a traditional Chinese medicine formulain the treatment of primary liver cancer. Methods: Systems pharmacology and gene chip target predictions were performed for the traditional Chinese medicine formula ZhenzhuXiaojiTang (ZZXJT). A third square alignment was performed with molecular docking. Results: Identification of systems pharmacology accounted for 17% of targets, whilegene chip-predicted outcomes accounted for 19%.Molecular docking showed that the top ten targets (excludingcommon targets) of the system pharmacology model had better binding free energies than the gene chip model using twocommon targets as a benchmark. For both models, the core drugs predictions were more consistent than the core small molecules predictions. Conclusion:In this study, the identified targets of systems pharmacology weredissimilar to those identified by gene chip technology; whereas the core drug and small molecule predictions were similar.
format Online
Article
Text
id pubmed-8926147
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89261472022-03-17 A Comparative Study of Systems Pharmacology and Gene Chip Technology for Predicting Targets of a Traditional Chinese Medicine Formula in Primary Liver Cancer Treatment Li, Songzhe Sun, Yang Sun, Yue Front Pharmacol Pharmacology Background: The systems pharmacology approach is a target prediction model for traditional Chinese medicine and has been used increasingly in recent years. However, the accuracy of this model to other prediction models is yet to be established. Objective : To compare the systems pharmacology modelwithexperimental gene chip technology by using these models to predict targets of a traditional Chinese medicine formulain the treatment of primary liver cancer. Methods: Systems pharmacology and gene chip target predictions were performed for the traditional Chinese medicine formula ZhenzhuXiaojiTang (ZZXJT). A third square alignment was performed with molecular docking. Results: Identification of systems pharmacology accounted for 17% of targets, whilegene chip-predicted outcomes accounted for 19%.Molecular docking showed that the top ten targets (excludingcommon targets) of the system pharmacology model had better binding free energies than the gene chip model using twocommon targets as a benchmark. For both models, the core drugs predictions were more consistent than the core small molecules predictions. Conclusion:In this study, the identified targets of systems pharmacology weredissimilar to those identified by gene chip technology; whereas the core drug and small molecule predictions were similar. Frontiers Media S.A. 2022-03-02 /pmc/articles/PMC8926147/ /pubmed/35308212 http://dx.doi.org/10.3389/fphar.2022.768862 Text en Copyright © 2022 Li, Sun and Sun. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Li, Songzhe
Sun, Yang
Sun, Yue
A Comparative Study of Systems Pharmacology and Gene Chip Technology for Predicting Targets of a Traditional Chinese Medicine Formula in Primary Liver Cancer Treatment
title A Comparative Study of Systems Pharmacology and Gene Chip Technology for Predicting Targets of a Traditional Chinese Medicine Formula in Primary Liver Cancer Treatment
title_full A Comparative Study of Systems Pharmacology and Gene Chip Technology for Predicting Targets of a Traditional Chinese Medicine Formula in Primary Liver Cancer Treatment
title_fullStr A Comparative Study of Systems Pharmacology and Gene Chip Technology for Predicting Targets of a Traditional Chinese Medicine Formula in Primary Liver Cancer Treatment
title_full_unstemmed A Comparative Study of Systems Pharmacology and Gene Chip Technology for Predicting Targets of a Traditional Chinese Medicine Formula in Primary Liver Cancer Treatment
title_short A Comparative Study of Systems Pharmacology and Gene Chip Technology for Predicting Targets of a Traditional Chinese Medicine Formula in Primary Liver Cancer Treatment
title_sort comparative study of systems pharmacology and gene chip technology for predicting targets of a traditional chinese medicine formula in primary liver cancer treatment
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926147/
https://www.ncbi.nlm.nih.gov/pubmed/35308212
http://dx.doi.org/10.3389/fphar.2022.768862
work_keys_str_mv AT lisongzhe acomparativestudyofsystemspharmacologyandgenechiptechnologyforpredictingtargetsofatraditionalchinesemedicineformulainprimarylivercancertreatment
AT sunyang acomparativestudyofsystemspharmacologyandgenechiptechnologyforpredictingtargetsofatraditionalchinesemedicineformulainprimarylivercancertreatment
AT sunyue acomparativestudyofsystemspharmacologyandgenechiptechnologyforpredictingtargetsofatraditionalchinesemedicineformulainprimarylivercancertreatment
AT lisongzhe comparativestudyofsystemspharmacologyandgenechiptechnologyforpredictingtargetsofatraditionalchinesemedicineformulainprimarylivercancertreatment
AT sunyang comparativestudyofsystemspharmacologyandgenechiptechnologyforpredictingtargetsofatraditionalchinesemedicineformulainprimarylivercancertreatment
AT sunyue comparativestudyofsystemspharmacologyandgenechiptechnologyforpredictingtargetsofatraditionalchinesemedicineformulainprimarylivercancertreatment